FDA Says No To Nicox, Lundbeck's Persistence Pays Off, It's A Win For LPCN

Nicox S.A.'s AC-170, a proprietary cetirizine eye drop formulation, proposed for the treatment of ocular itching associated with allergic conjunctivitis has been turned down by the FDA.

from RTT - Biotech http://ift.tt/2dVHd5b
via IFTTT